These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 30371287

  • 1. Prognostic Impact of Multiple Prior Percutaneous Coronary Interventions in Patients Undergoing Coronary Artery Bypass Grafting.
    Biancari F, Dalén M, Ruggieri VG, Demal T, Gatti G, Onorati F, Faggian G, Rubino AS, Maselli D, Gherli R, Salsano A, Saccocci M, Santarpino G, Nicolini F, Tauriainen T, De Feo M, Airaksinen J, Rosato S, Perrotti A, Mariscalco G.
    J Am Heart Assoc; 2018 Oct 16; 7(20):e010089. PubMed ID: 30371287
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial.
    Morice MC, Serruys PW, Kappetein AP, Feldman TE, Ståhle E, Colombo A, Mack MJ, Holmes DR, Choi JW, Ruzyllo W, Religa G, Huang J, Roy K, Dawkins KD, Mohr F.
    Circulation; 2014 Jun 10; 129(23):2388-94. PubMed ID: 24700706
    [Abstract] [Full Text] [Related]

  • 4. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
    Cohen DJ, Osnabrugge RL, Magnuson EA, Wang K, Li H, Chinnakondepalli K, Pinto D, Abdallah MS, Vilain KA, Morice MC, Dawkins KD, Kappetein AP, Mohr FW, Serruys PW, SYNTAX Trial Investigators.
    Circulation; 2014 Sep 30; 130(14):1146-57. PubMed ID: 25085960
    [Abstract] [Full Text] [Related]

  • 5. Impact of SYNTAX Score on 10-Year Outcomes After Revascularization for Left Main Coronary Artery Disease.
    Yoon YH, Ahn JM, Kang DY, Park H, Cho SC, Lee PH, Lee SW, Park SW, Park DW, Park SJ.
    JACC Cardiovasc Interv; 2020 Feb 10; 13(3):361-371. PubMed ID: 32029254
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Left Main Coronary Artery Disease Revascularization According to the SYNTAX Score.
    Shlofmitz E, Généreux P, Chen S, Dressler O, Ben-Yehuda O, Morice MC, Puskas JD, Taggart DP, Kandzari DE, Crowley A, Redfors B, Mehdipoor G, Kappetein AP, Sabik JF, Serruys PW, Stone GW.
    Circ Cardiovasc Interv; 2019 Sep 10; 12(9):e008007. PubMed ID: 31495220
    [Abstract] [Full Text] [Related]

  • 8. Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up.
    Iqbal J, Zhang YJ, Holmes DR, Morice MC, Mack MJ, Kappetein AP, Feldman T, Stahle E, Escaned J, Banning AP, Gunn JP, Colombo A, Steyerberg EW, Mohr FW, Serruys PW.
    Circulation; 2015 Apr 07; 131(14):1269-77. PubMed ID: 25847979
    [Abstract] [Full Text] [Related]

  • 9. Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective.
    Osnabrugge RL, Magnuson EA, Serruys PW, Campos CM, Wang K, van Klaveren D, Farooq V, Abdallah MS, Li H, Vilain KA, Steyerberg EW, Morice MC, Dawkins KD, Mohr FW, Kappetein AP, Cohen DJ, SYNTAX trial investigators.
    Heart; 2015 Dec 07; 101(24):1980-8. PubMed ID: 26552756
    [Abstract] [Full Text] [Related]

  • 10. Analysis of stroke occurring in the SYNTAX trial comparing coronary artery bypass surgery and percutaneous coronary intervention in the treatment of complex coronary artery disease.
    Mack MJ, Head SJ, Holmes DR, Ståhle E, Feldman TE, Colombo A, Morice MC, Unger F, Erglis A, Stoler R, Dawkins KD, Serruys PW, Mohr FW, Kappetein AP.
    JACC Cardiovasc Interv; 2013 Apr 07; 6(4):344-54. PubMed ID: 23523456
    [Abstract] [Full Text] [Related]

  • 11. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
    Head SJ, Milojevic M, Daemen J, Ahn JM, Boersma E, Christiansen EH, Domanski MJ, Farkouh ME, Flather M, Fuster V, Hlatky MA, Holm NR, Hueb WA, Kamalesh M, Kim YH, Mäkikallio T, Mohr FW, Papageorgiou G, Park SJ, Rodriguez AE, Sabik JF, Stables RH, Stone GW, Serruys PW, Kappetein AP.
    J Am Coll Cardiol; 2018 Jul 24; 72(4):386-398. PubMed ID: 30025574
    [Abstract] [Full Text] [Related]

  • 12. Ten-Year All-Cause Death According to Completeness of Revascularization in Patients With Three-Vessel Disease or Left Main Coronary Artery Disease: Insights From the SYNTAX Extended Survival Study.
    Takahashi K, Serruys PW, Gao C, Ono M, Wang R, Thuijs DJFM, Mack MJ, Curzen N, Mohr FW, Davierwala P, Milojevic M, Wykrzykowska JJ, de Winter RJ, Sharif F, Onuma Y, Head SJ, Kappetein AP, Morice MC, Holmes DR, SYNTAX Extended Survival Study Investigators.
    Circulation; 2021 Jul 13; 144(2):96-109. PubMed ID: 34011163
    [Abstract] [Full Text] [Related]

  • 13. Three-year outcomes after percutaneous coronary intervention and coronary artery bypass grafting in patients with heart failure: from the CREDO-Kyoto percutaneous coronary intervention/coronary artery bypass graft registry cohort-2†.
    Marui A, Kimura T, Nishiwaki N, Komiya T, Hanyu M, Shiomi H, Tanaka S, Sakata R, CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators.
    Eur J Cardiothorac Surg; 2015 Feb 13; 47(2):316-21; discussion 321. PubMed ID: 24662243
    [Abstract] [Full Text] [Related]

  • 14. Mortality After Repeat Revascularization Following PCI or CABG for Left Main Disease: The EXCEL Trial.
    Giustino G, Serruys PW, Sabik JF, Mehran R, Maehara A, Puskas JD, Simonton CA, Lembo NJ, Kandzari DE, Morice MC, Taggart DP, Gershlick AH, Ragosta M, Kron IL, Liu Y, Zhang Z, McAndrew T, Dressler O, Généreux P, Ben-Yehuda O, Pocock SJ, Kappetein AP, Stone GW.
    JACC Cardiovasc Interv; 2020 Feb 10; 13(3):375-387. PubMed ID: 31954680
    [Abstract] [Full Text] [Related]

  • 15. Incidence, correlates, and significance of abnormal cardiac enzyme rises in patients treated with surgical or percutaneous based revascularisation: a substudy from the Synergy between Percutaneous Coronary Interventions with Taxus and Cardiac Surgery (SYNTAX) Trial.
    Farooq V, Serruys PW, Vranckx P, Bourantas CV, Girasis C, Holmes DR, Kappetein AP, Mack M, Feldman T, Morice MC, Colombo A, Morel MA, de Vries T, Dawkins KD, Mohr FW, James S, Ståhle E.
    Int J Cardiol; 2013 Oct 15; 168(6):5287-92. PubMed ID: 23993326
    [Abstract] [Full Text] [Related]

  • 16. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial.
    Thuijs DJFM, Kappetein AP, Serruys PW, Mohr FW, Morice MC, Mack MJ, Holmes DR, Curzen N, Davierwala P, Noack T, Milojevic M, Dawkins KD, da Costa BR, Jüni P, Head SJ, SYNTAX Extended Survival Investigators.
    Lancet; 2019 Oct 12; 394(10206):1325-1334. PubMed ID: 31488373
    [Abstract] [Full Text] [Related]

  • 17. Outcomes After Coronary Stenting or Bypass Surgery for Men and Women With Unprotected Left Main Disease: The EXCEL Trial.
    Serruys PW, Cavalcante R, Collet C, Kappetein AP, Sabik JF, Banning AP, Taggart DP, Sabaté M, Pomar J, Boonstra PW, Lembo NJ, Onuma Y, Simonton CA, Morice MC, McAndrew T, Dressler O, Stone GW.
    JACC Cardiovasc Interv; 2018 Jul 09; 11(13):1234-1243. PubMed ID: 29976359
    [Abstract] [Full Text] [Related]

  • 18. Percutaneous Coronary Intervention in Native Coronary Arteries Versus Bypass Grafts in Patients With Prior Coronary Artery Bypass Graft Surgery: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.
    Brilakis ES, O'Donnell CI, Penny W, Armstrong EJ, Tsai T, Maddox TM, Plomondon ME, Banerjee S, Rao SV, Garcia S, Nallamothu B, Shunk KA, Mavromatis K, Grunwald GK, Bhatt DL.
    JACC Cardiovasc Interv; 2016 May 09; 9(9):884-93. PubMed ID: 27085582
    [Abstract] [Full Text] [Related]

  • 19. Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Prior Cerebrovascular Disease: Results From the EXCEL Trial.
    Diamond J, Madhavan MV, Sabik JF, Serruys PW, Kappetein AP, Leon MB, Taggart DP, Berland J, Morice MC, Gersh BJ, Kandzari DE, Dressler O, Stone GW.
    JACC Cardiovasc Interv; 2018 Dec 24; 11(24):2441-2450. PubMed ID: 30573053
    [Abstract] [Full Text] [Related]

  • 20. Quality of Life After Surgery or DES in Patients With 3-Vessel or Left Main Disease.
    Abdallah MS, Wang K, Magnuson EA, Osnabrugge RL, Kappetein AP, Morice MC, Mohr FA, Serruys PW, Cohen DJ, SYNTAX Trial Investigators.
    J Am Coll Cardiol; 2017 Apr 25; 69(16):2039-2050. PubMed ID: 28427580
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.